South Korea - Antihypertensive Medicine Use
Since 2014, South Korea Antihypertensive Medicine Use fell by 4.8% year on year. With 1.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 27 comparing other countries in Antihypertensive Medicine Use. South Korea is overtaken by Norway, which was ranked number 26 at 2.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Portugal with 1.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary lead the ranking with 34.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, +4.2% compared to 2018. Lithuania, Slovakia and Slovenia respectively ranked number 2, 3 and 4 in this ranking. Canada witnessed the best average annual growth at +10.3% per year, while Slovakia was the worst growing country at -9.8% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 1.80 |
| 2018 | 1.90 |
| 2017 | 1.90 |
| 2016 | 2.00 |
| 2015 | 2.20 |
How does South Korea rank in Antihypertensive Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Hungary
|
35 | 2019 | +4.2 % | +4.2 % | View data | |
| 2 |
#2
Lithuania
|
24 | 2019 | +4.7 % | -3.6 % | View data | |
| 26 |
#26
Norway
|
3 | 2019 | -21.9 % | -9.4 % | View data | |
| 27 |
#27
South Korea
|
2 | 2019 | -5.3 % | -4.8 % | View data | |
| 28 |
#28
Portugal
|
1 | 2019 | +0.0 % | +0.0 % | View data | |